ATHA   $0.229  -5.80% Market Closed

Athira Pharma, Inc.
Total Cash 91.77M
totalCashPerShare 2.387
EBITDA -120.43M
Total Debt 1.41M
quickRatio 3.472
currentRatio 3.966
Total Revenue
debtToEquity 1.688
Revenue/Share
ROA -0.47525
ROE -0.84566003
grossProfits
freeCashflow -68.05M
operatingCashflow -98.41M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -61.53M
forwardPE -0.42944786
floatShares 26.96M
sharesOutstanding 38.44M
sharesShort 1.56M
sharesShortPriorMonth 1.65M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.63%
Short Ratio help_outline 2.74%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 2.168
Price To Book help_outline 0.32
earningsQuarterlyGrowth
netIncomeToCommon -113.45M
trailingEps -2.97%
forwardEps -1.63%
enterpriseToEbitda 0.51
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.71 3Q 2024
institutionsCount 81
lastUpdated Nov. 7, 2024, 3:25 a.m.